SLNCF — Silence Therapeutics plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1479615 ·
United Kingdom
Last close
$5.50
Market Cap
$1.03B
52W High
$5.99
52W Low
$1.06
ADV30
90
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 422,000 | 411,000 | -15,737,000 | -14,957,000 | 115,123,000 | 5,657,000 | 65,721,000 |
| Dec 2025 | 34,000 | 22,000 | -12,461,000 | -11,770,000 | 131,442,000 | 11,277,000 | 69,138,000 |
| Sep 2025 | 159,000 | 95,000 | -26,244,000 | -20,958,000 | 146,790,000 | 82,031,000 | 72,727,000 |
| Jun 2025 | 224,000 | 139,000 | -22,639,000 | -27,354,000 | 165,233,000 | 41,739,000 | 71,078,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-65,565,000
Investing CF
$6,389,000
Financing CF
$1,000
CapEx
$-110,768
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.65
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-577,526,000
Inventory
—
Receivables
$22,216,000
ST Investments
$64,421,000
EBIT TTM
$-77,081,000
Pretax Income TTM
$-75,028,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$615,000
EBITDA
$-63,942,000
Free Cash Flow
$-23,567,624
Enterprise Value
$707,628,224
Total Cash
$72,054,000
Total Debt
$112,000
Shares Out
186,462,258
Trailing EPS
$-0.43
Book Value
$0.27
ROE
-90.4%
ROA
-29.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 559,000 | -89,753,000 | -88,612,000 | 131,442,000 | 69,138,000 | — | -62,271,000 |
| Dec 2024 | 43,258,000 | -63,319,000 | -45,309,000 | 202,635,000 | 68,612,000 | — | -67,640,000 |
| Dec 2023 | 31,643,000 | -64,383,000 | -54,228,000 | 119,448,000 | 97,455,000 | — | -49,462,000 |
| Dec 2022 | 21,655,000 | -61,040,000 | -50,334,000 | 130,096,453 | 103,384,928 | — | -57,044,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.38
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | $1.03B | $5.20 | — |
| LXRX | LEXICON PHARMACEUTICALS, INC. | $1.03B | $2.32 | — |
| AVTX | Avalo Therapeutics, Inc. | $1.03B | $19.27 | — |
| WVE | Wave Life Sciences, Inc. | $1.01B | $5.12 | — |
| PCRX | Pacira BioSciences, Inc. | $978.19M | $24.86 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Higher Monday
2026-03-16 15:22 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
2026-03-10 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
2026-03-09 15:30 · Yahoo
Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High?
2026-03-05 14:55 · Yahoo
European Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading
2026-03-02 16:07 · Yahoo
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
2026-02-19 12:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading
2025-11-13 16:19 · Yahoo
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday
2025-10-28 14:59 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
2025-10-15 14:57 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
2025-10-13 15:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.